Milrinone vs norepinephrine administration in preventing delayed cerebral ischaemia in cerebral vasospasm: a systematic review

Author:

Dooley Rachael1,Nugent Linda2,Moore Zena3,Patton Declan4,O'Connor Tom5

Affiliation:

1. Candidate Stroke Advanced Nurse Practitioner, Mater Misericordiae University Hospital, Dublin, Ireland

2. Deputy Director of Academic Affairs of School of Nursing and Midwifery, Royal College of Surgeons in Ireland

3. Professor and Head of School of Nursing and Midwifery, Royal College of Surgeons in Ireland

4. Director of Research of School of Nursing and Midwifery, Royal College of Surgeons in Ireland

5. Deputy Head of School and Director of Academic Affairs of School of Nursing and Midwifery, Royal College of Surgeons in Ireland

Abstract

Background: Subarachnoid haemorrhage is a form of stroke, classified as traumatic or aneurysmal in origin. Subarachnoid haemorrhage from aneurysmal rupture can cause significant side effects—most frequently, cerebral vasospasm, which increases the risk of developing delayed cerebral ischaemia. Medical and endovascular interventions differ between institutions and regions. However, the most common intervention is medication management with milrinone and norepinephrine. Aims: This systematic review determines the effectiveness of milrinone versus norepinephrine administration in preventing delayed cerebral ischaemia in aneurysmal subarachnoid haemorrhage patients with cerebral vasospasm. Methods: Critical appraisal of 13 studies, consisting of randomised controlled trials, prospective/retrospective case series and reports and cross setional studies, was conducted. Findings: There was considerable variation in dosing and co-interventions for both milrinone and norepinephrine administration. Some 11 studies agreed milrinone was more beneficial in increasing cerebral blood flow than norepinephrine. For milrinone, good functional outcomes were identified in 60–100% of assessed populations, compared to 44–64% with norephinephrine. For both medications poor outcomes related to an increased severity of haemorrhage. Adverse effects following milrinone administration were seen in three studies, but were deemed negligible compared to treatment benefit. Only one norepinephrine study reported severe adverse events. Conclusions: Milrinone appears to be more beneficial than norepinephrine in preventing delayed cerebral ischaemia, improving functional outcomes and causing less adverse effects. Owing to the low quality of evidence supporting milrinone use in subarachnoid haemorrhgae, further research is needed.

Publisher

Mark Allen Group

Subject

Neurology (clinical),General Nursing

Reference58 articles.

1. Milrinone Reduces Cerebral Vasospasm After Subarachnoid Hemorrhage of WFNS Grade IV or V

2. Ayres JK, Maani CV. Milrinone. Florida: StatPearls Publishing; 2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3